Gene therapy for thalassemia ends need for transfusions in young children: Phase 3 clinical trial…
Over 90 percent of patients with transfusion-dependent thalassemia, an inherited blood disorder, no longer needed monthly blood transfusions years after receiving gene therapy, according to an international Phase 3 clinical trial that for…